Related Experiment Video
Updated: Mar 28, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Caveolin-3 Promotes a Vascular Smooth Muscle Contractile Phenotype
Jorge L Gutierrez-Pajares1, Jeannette Iturrieta2, Vipin Dulam2
1Faculté de Médecine, INSERM UMR1069 "Nutrition, Croissance et Cancer", Université François Rabelais de Tours , Tours , France ; Department of Stem Cell Biology and Regenerative Medicine, Kimmel Cancer Center, Thomas Jefferson University , Philadelphia, PA , USA ; Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University , Philadelphia, PA , USA.
Caveolin-3 expression in smooth muscle (SM) cells promotes a contractile phenotype and reduces proliferation and apoptosis. This finding is crucial for understanding vascular diseases like atherosclerosis and restenosis.
Area of Science:
- Vascular Biology
- Cellular Phenotype Regulation
- Cardiovascular Disease Pathophysiology
Background:
- Cardiovascular diseases are a major health concern in Western countries.
- Vascular smooth muscle (SM) cells play a critical role in vascular tone, atherosclerosis, and restenosis.
- SM cells exhibit a phenotypic switch from contractile to synthetic states during vascular disease development.
Purpose of the Study:
- To investigate the role of caveolin-3 in regulating the phenotype of vascular SM cells.
- To determine how caveolin-3 expression affects SM cell contractility, proliferation, and apoptosis.
Main Methods:
- Examined caveolin-3 expression in vivo and in cultured SM cells.
- Assessed the expression of contractility and synthetic phenotype markers in SM cells with and without caveolin-3.
- Evaluated the effect of caveolin-3 on SM cell proliferation and apoptosis in response to stimuli like LDL and PDGF.
Main Results:
- Caveolin-3 expression in SM cells correlated with increased contractility markers (SM α-actin, SM myosin heavy chain) and decreased synthetic markers (p-Elk, Klf4).
- Caveolin-3 expression reduced SM cell proliferation when treated with LDL or PDGF.
- SM cells expressing caveolin-3 showed reduced sensitivity to apoptosis induced by oxidized LDL.
Conclusions:
- Caveolin-3 acts as a regulator of the phenotypic switch between contractile and synthetic vascular SM cells.
- Understanding caveolin-3's role can enhance comprehension of SM cell function in atherosclerosis and restenosis.
- Targeting caveolin-3 may offer therapeutic potential for vascular diseases.
More Related Videos
08:59Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle
Published on: May 5, 2022
10:57Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017
Related Concept Videos
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Regulation of Angiogenesis and Blood Supply
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Nitric Oxide Signaling Pathway
Vascular Spasm